A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes.

Pena, Michelle J

A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes. [electronic resource] - PloS one 2015 - e0120995 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1932-6203

10.1371/journal.pone.0120995 doi


Adaptor Proteins, Signal Transducing
Adipokines--blood
Adult
Aged
Biomarkers--blood
Bone Morphogenetic Proteins--blood
Chemokine CCL2--blood
Chitinase-3-Like Protein 1
Connective Tissue Growth Factor--blood
Diabetes Mellitus, Type 2--blood
Diabetic Nephropathies--blood
Disease Progression
Female
Fibrosis
Genetic Markers
Glomerular Filtration Rate
Humans
Intracellular Signaling Peptides and Proteins--blood
Kidney--metabolism
Lectins--blood
Male
Matrix Metalloproteinases, Secreted--blood
Membrane Proteins--blood
Middle Aged
Natriuretic Peptide, C-Type--blood
Outpatients
Prognosis
Prospective Studies
Protein-Tyrosine Kinases--blood
Receptors, Tumor Necrosis Factor, Type I--blood
Renal Insufficiency, Chronic--blood
Risk Factors